Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × Fluid Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 2 Lymphoma 2 Tuberous Sclerosis 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, Mantle-Cell 1 Leukemia, Myeloid, Acute 1 Epilepsy 1 Diffuse Intrinsic Pontine Glioma 1 Cut-Off Value 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Breast Cancer Lymphedema 1

Interventions

Everolimus 14 Sirolimus 13 Cannabidiol 4 radiprodil 3 ganaxolone 3 Activator Appliances 3 Vigabatrin 2 Melatonin 2 exemestane 1 dactolisib 1 carbon-11 acetate 1 Urination 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Solutions 1 Simvastatin 1 Propranolol 1 Phlebotomy 1 Itraconazole 1 Injections 1 Genetic Testing 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Carbamazepine 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1 Actigraphy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Recruiting

Epilepsy, Neoplasms, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡